[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100600388":3},{"organization":4,"outcomesModule":7,"designInfo":55,"detailedDescription":61,"studyPopulation":54,"armGroups":62,"interventions":74,"overallOfficials":54,"centralContacts":82,"locations":88,"responsibleParty":418,"collaborators":54,"id":420,"slug":421,"hasResults":422,"nctId":423,"briefTitle":424,"officialTitle":425,"acronym":426,"eligibilityCriteria":427,"healthyVolunteers":422,"sex":428,"minAge":429,"maxAge":430,"enrollmentInfo":431,"targetDuration":54,"studyType":434,"phases":435,"briefSummary":437,"conditions":438,"keywords":440,"overallStatus":91,"whyStopped":54,"lastUpdateSubmitDate":443,"lastUpdatePostDateStruct":444,"startDateStruct":447,"completionDateStruct":449,"leadSponsor":451,"locationsCount":452},{"fullName":5,"class":6},"Climb Bio, Inc.","INDUSTRY",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":54},[9],{"measure":10,"description":11,"timeFrame":12},"Incidence of Treatment-Emergent Adverse Events (TEAEs)","Number of participants experiencing TEAEs, graded per NCI CTCAE v5.0.","Up to Week 48",[14,17,20,24,27,30,33,36,39,42,45,48,51],{"measure":15,"description":16,"timeFrame":12},"Change in total B Cell Count","Absolute and % change in total number of peripheral B cells over time.",{"measure":18,"description":19,"timeFrame":12},"Change in Anti-PLA2R Antibodies","Change from Baseline in anti-PLA2R antibody titers over time.",{"measure":21,"description":22,"timeFrame":23},"Complete Remission Rate","Proportion of subjects who achieve complete remission at Week 48.","Week 48",{"measure":25,"description":26,"timeFrame":23},"Complete or Partial Remission Rate","Proportion of subjects who achieve complete or partial remission at Week 48.",{"measure":28,"description":29,"timeFrame":12},"Change in Proteinuria","Change from Baseline in proteinuria (measured via urine protein-creatinine ratio, UPCR) over time.",{"measure":31,"description":32,"timeFrame":12},"Change in UACR","Change in urine albumin-to-creatinine ratio over time.",{"measure":34,"description":35,"timeFrame":12},"Change in eGFR","Change from Baseline in eGFR over time.",{"measure":37,"description":38,"timeFrame":12},"Area Under the Curve (AUC)","Measurement of the area under the drug concentration-time curve.",{"measure":40,"description":41,"timeFrame":12},"Maximum Observed Plasma Concentration (Cmax)","Measurement of the maximum observed plasma concentration.",{"measure":43,"description":44,"timeFrame":12},"Time to Maximum Observed Concentration (Tmax)","Measurement of the time to maximum observed concentration.",{"measure":46,"description":47,"timeFrame":12},"Terminal Half-Life (T1\u002F2)","Measurement of the terminal half-life in days.",{"measure":49,"description":50,"timeFrame":12},"Apparent Clearance (CL\u002FF)","Measurement of the apparent clearance in L\u002Fhour.",{"measure":52,"description":53,"timeFrame":12},"Volume of Distribution (Vd)","Measurement of the volume of distribution in liters.",null,{"allocation":56,"interventionModel":57,"interventionModelDescription":54,"primaryPurpose":58,"observationalModel":54,"timePerspective":54,"maskingInfo":59},"NON_RANDOMIZED","SEQUENTIAL","TREATMENT",{"masking":60,"maskingDescription":54,"whoMasked":54},"NONE","Budoprutug is a humanized, immunoglobulin (Ig) G1 monoclonal antibody that selectively binds to CD19 and is projected to deplete targeted cells through antibody-dependent cellular cytotoxicity (ADCC). This Phase 2, open-label, multicenter study evaluates the safety, pharmacodynamics, and preliminary efficacy of three intravenous dose regimens of budoprutug in adult subjects with primary membranous nephropathy (PMN) who are anti-PLA2R antibody positive and have persistent proteinuria despite optimized RAAS inhibition. Approximately 45 subjects will be enrolled across three sequential dose cohorts, each receiving a single IV dose of budoprutug on Day 1, Day 15, Day 169 and Day 183. Subjects will be followed through Week 48, with extended follow-up for B-cell recovery as needed.",[63,68,71],{"label":64,"type":65,"description":54,"interventionNames":66},"Cohort 1: Dose Level A","EXPERIMENTAL",[67],"Drug: budoprutug",{"label":69,"type":65,"description":54,"interventionNames":70},"Cohort 2: Dose Level B",[67],{"label":72,"type":65,"description":54,"interventionNames":73},"Cohort 3: Dose Level C",[67],[75],{"type":76,"name":77,"description":78,"armGroupLabels":79,"otherNames":80},"DRUG","budoprutug","Single IV dose of study product on Day 1, Day 15, Day 169 and Day 183",[64,69,72],[81],"TNT119",[83],{"name":84,"role":85,"phone":86,"phoneExt":54,"email":87},"Climb Bio Study Director","CONTACT","+1 866 857 2596","clinicaltrials@climbbio.com",[89,103,113,123,133,143,153,164,170,174,177,186,197,206,215,224,233,238,251,258,268,278,288,297,307,314,324,330,336,347,356,362,368,374,385,394,400,409],{"facility":90,"status":91,"city":92,"state":93,"zip":94,"country":95,"countryCode":96,"cosmosGeoPoint":97,"geoPoint":102,"contacts":54},"Climb Bio Investigative Site #110","RECRUITING","Denver","Colorado","80220","United States","US",{"type":98,"coordinates":99},"Point",[100,101],-104.9847,39.73915,{"lat":101,"lon":100},{"facility":104,"status":91,"city":105,"state":106,"zip":107,"country":95,"countryCode":96,"cosmosGeoPoint":108,"geoPoint":112,"contacts":54},"Climb Bio Investigative Site #105","Orlando","Florida","32086",{"type":98,"coordinates":109},[110,111],-81.37924,28.53834,{"lat":111,"lon":110},{"facility":114,"status":91,"city":115,"state":116,"zip":117,"country":95,"countryCode":96,"cosmosGeoPoint":118,"geoPoint":122,"contacts":54},"Climb Bio Investigative Site #108","Atlanta","Georgia","30342",{"type":98,"coordinates":119},[120,121],-84.38798,33.749,{"lat":121,"lon":120},{"facility":124,"status":91,"city":125,"state":126,"zip":127,"country":95,"countryCode":96,"cosmosGeoPoint":128,"geoPoint":132,"contacts":54},"Climb Bio Investigative Site #106","Indianapolis","Indiana","46268",{"type":98,"coordinates":129},[130,131],-86.15804,39.76838,{"lat":131,"lon":130},{"facility":134,"status":91,"city":135,"state":136,"zip":137,"country":95,"countryCode":96,"cosmosGeoPoint":138,"geoPoint":142,"contacts":54},"Climb Bio Investigative Site #101","Clifton Park","New York","12065",{"type":98,"coordinates":139},[140,141],-73.77095,42.86563,{"lat":141,"lon":140},{"facility":144,"status":91,"city":145,"state":146,"zip":147,"country":95,"countryCode":96,"cosmosGeoPoint":148,"geoPoint":152,"contacts":54},"Climb Bio Investigative Site #104","Sherman","Texas","75092",{"type":98,"coordinates":149},[150,151],-96.60888,33.63566,{"lat":151,"lon":150},{"facility":154,"status":91,"city":155,"state":54,"zip":156,"country":157,"countryCode":158,"cosmosGeoPoint":159,"geoPoint":163,"contacts":54},"Climb Bio Investigative Site# 602","Buenos Aires","B1629","Argentina","AR",{"type":98,"coordinates":160},[161,162],-58.37723,-34.61315,{"lat":162,"lon":161},{"facility":165,"status":91,"city":155,"state":54,"zip":166,"country":157,"countryCode":158,"cosmosGeoPoint":167,"geoPoint":169,"contacts":54},"Climb Bio Investigative Site# 603","B1888",{"type":98,"coordinates":168},[161,162],{"lat":162,"lon":161},{"facility":171,"status":91,"city":172,"state":54,"zip":173,"country":157,"countryCode":158,"cosmosGeoPoint":54,"geoPoint":54,"contacts":54},"Climb Bio Investigative Site #601","CABA","C1111",{"facility":175,"status":91,"city":172,"state":54,"zip":176,"country":157,"countryCode":158,"cosmosGeoPoint":54,"geoPoint":54,"contacts":54},"Climb Bio Investigative Site #604","C1425",{"facility":178,"status":91,"city":179,"state":54,"zip":180,"country":157,"countryCode":158,"cosmosGeoPoint":181,"geoPoint":185,"contacts":54},"Climb Bio Investigative Site #606","Santa Fe","S3000",{"type":98,"coordinates":182},[183,184],-60.70868,-31.64881,{"lat":184,"lon":183},{"facility":187,"status":91,"city":188,"state":54,"zip":189,"country":190,"countryCode":191,"cosmosGeoPoint":192,"geoPoint":196,"contacts":54},"Climb Bio Investigative Site #502","Belo Horizonte","30150-320","Brazil","BR",{"type":98,"coordinates":193},[194,195],-43.93778,-19.92083,{"lat":195,"lon":194},{"facility":198,"status":91,"city":199,"state":54,"zip":200,"country":190,"countryCode":191,"cosmosGeoPoint":201,"geoPoint":205,"contacts":54},"Climb Bio Investigative Site #505","Minas Gerais","36010-570",{"type":98,"coordinates":202},[203,204],-72.78333,-8.96667,{"lat":204,"lon":203},{"facility":207,"status":91,"city":208,"state":54,"zip":209,"country":190,"countryCode":191,"cosmosGeoPoint":210,"geoPoint":214,"contacts":54},"Climb Bio Investigative Site #506","Pernambuco","50670-901",{"type":98,"coordinates":211},[212,213],-71.47582,-6.98059,{"lat":213,"lon":212},{"facility":216,"status":91,"city":217,"state":54,"zip":218,"country":190,"countryCode":191,"cosmosGeoPoint":219,"geoPoint":223,"contacts":54},"Climb Bio Investigative Site #501","Porto Alegre","90020-090",{"type":98,"coordinates":220},[221,222],-51.23019,-30.03283,{"lat":222,"lon":221},{"facility":225,"status":91,"city":226,"state":54,"zip":227,"country":190,"countryCode":191,"cosmosGeoPoint":228,"geoPoint":232,"contacts":54},"Climb Bio Investigative Site #503","São Paulo","05403-000",{"type":98,"coordinates":229},[230,231],-46.63611,-23.5475,{"lat":231,"lon":230},{"facility":234,"status":91,"city":226,"state":54,"zip":227,"country":190,"countryCode":191,"cosmosGeoPoint":235,"geoPoint":237,"contacts":54},"Climb Bio Investigative Site #504",{"type":98,"coordinates":236},[230,231],{"lat":231,"lon":230},{"facility":239,"status":240,"city":241,"state":242,"zip":243,"country":244,"countryCode":245,"cosmosGeoPoint":246,"geoPoint":250,"contacts":54},"Climb Bio Investigative Site #403","NOT_YET_RECRUITING","Beijing","Changping District","102218","China","CN",{"type":98,"coordinates":247},[248,249],116.39723,39.9075,{"lat":249,"lon":248},{"facility":252,"status":91,"city":241,"state":253,"zip":254,"country":244,"countryCode":245,"cosmosGeoPoint":255,"geoPoint":257,"contacts":54},"Climb Bio Investigative Site #401","Cheng District","100034",{"type":98,"coordinates":256},[248,249],{"lat":249,"lon":248},{"facility":259,"status":240,"city":260,"state":261,"zip":262,"country":244,"countryCode":245,"cosmosGeoPoint":263,"geoPoint":267,"contacts":54},"Climb Bio Investigative Site #408","Shenzhen","Guangdong","518036",{"type":98,"coordinates":264},[265,266],114.0683,22.54554,{"lat":266,"lon":265},{"facility":269,"status":91,"city":270,"state":271,"zip":272,"country":244,"countryCode":245,"cosmosGeoPoint":273,"geoPoint":277,"contacts":54},"Climb Bio Investigative Site #402","Wuxi","Jiangsu","214023",{"type":98,"coordinates":274},[275,276],120.28857,31.56887,{"lat":276,"lon":275},{"facility":279,"status":240,"city":280,"state":281,"zip":282,"country":244,"countryCode":245,"cosmosGeoPoint":283,"geoPoint":287,"contacts":54},"Climb Bio Investigative Site #405","Jinan","Shandong","250014",{"type":98,"coordinates":284},[285,286],116.99722,36.66833,{"lat":286,"lon":285},{"facility":289,"status":91,"city":290,"state":281,"zip":291,"country":244,"countryCode":245,"cosmosGeoPoint":292,"geoPoint":296,"contacts":54},"Climb Bio Investigative Site #409","Yantai","264000",{"type":98,"coordinates":293},[294,295],121.44081,37.47649,{"lat":295,"lon":294},{"facility":298,"status":91,"city":299,"state":300,"zip":301,"country":244,"countryCode":245,"cosmosGeoPoint":302,"geoPoint":306,"contacts":54},"Climb Bio Investigative Site #404","Yibin","Sichuan","644000",{"type":98,"coordinates":303},[304,305],104.63994,28.7593,{"lat":305,"lon":304},{"facility":308,"status":91,"city":241,"state":309,"zip":310,"country":244,"countryCode":245,"cosmosGeoPoint":311,"geoPoint":313,"contacts":54},"Climb Bio Investigative Site #406","Xicheng District","100044",{"type":98,"coordinates":312},[248,249],{"lat":249,"lon":248},{"facility":315,"status":91,"city":316,"state":54,"zip":317,"country":116,"countryCode":318,"cosmosGeoPoint":319,"geoPoint":323,"contacts":54},"Climb Bio Investigative Site #903","Tbilisi","0112","GE",{"type":98,"coordinates":320},[321,322],44.83412,41.69143,{"lat":322,"lon":321},{"facility":325,"status":91,"city":316,"state":54,"zip":326,"country":116,"countryCode":318,"cosmosGeoPoint":327,"geoPoint":329,"contacts":54},"Climb Bio Investigative Site #902","0114",{"type":98,"coordinates":328},[321,322],{"lat":322,"lon":321},{"facility":331,"status":91,"city":316,"state":54,"zip":332,"country":116,"countryCode":318,"cosmosGeoPoint":333,"geoPoint":335,"contacts":54},"Climb Bio Investigative Site #901","0144",{"type":98,"coordinates":334},[321,322],{"lat":322,"lon":321},{"facility":337,"status":91,"city":338,"state":54,"zip":339,"country":340,"countryCode":341,"cosmosGeoPoint":342,"geoPoint":346,"contacts":54},"Climb Bio Investigative Site #204","Taichung","404","Taiwan","TW",{"type":98,"coordinates":343},[344,345],120.6839,24.1469,{"lat":345,"lon":344},{"facility":348,"status":91,"city":349,"state":54,"zip":350,"country":340,"countryCode":341,"cosmosGeoPoint":351,"geoPoint":355,"contacts":54},"Climb Bio Investigative Site# 202","Taipei","100",{"type":98,"coordinates":352},[353,354],121.52639,25.05306,{"lat":354,"lon":353},{"facility":357,"status":91,"city":349,"state":54,"zip":358,"country":340,"countryCode":341,"cosmosGeoPoint":359,"geoPoint":361,"contacts":54},"Climb Bio Investigative Site# 201","110",{"type":98,"coordinates":360},[353,354],{"lat":354,"lon":353},{"facility":363,"status":91,"city":349,"state":54,"zip":364,"country":340,"countryCode":341,"cosmosGeoPoint":365,"geoPoint":367,"contacts":54},"Climb Bio Investigative Site #205","112",{"type":98,"coordinates":366},[353,354],{"lat":354,"lon":353},{"facility":369,"status":91,"city":349,"state":54,"zip":370,"country":340,"countryCode":341,"cosmosGeoPoint":371,"geoPoint":373,"contacts":54},"Climb Bio Investigative Site# 203","235",{"type":98,"coordinates":372},[353,354],{"lat":354,"lon":353},{"facility":375,"status":91,"city":376,"state":54,"zip":377,"country":378,"countryCode":379,"cosmosGeoPoint":380,"geoPoint":384,"contacts":54},"Climb Bio Investigative Site #803","Ivano-Frankivsk","76008","Ukraine","UA",{"type":98,"coordinates":381},[382,383],24.71248,48.92312,{"lat":383,"lon":382},{"facility":386,"status":91,"city":387,"state":54,"zip":388,"country":378,"countryCode":379,"cosmosGeoPoint":389,"geoPoint":393,"contacts":54},"Climb Bio Investigative Site# 801","Kyiv","02125",{"type":98,"coordinates":390},[391,392],30.5238,50.45466,{"lat":392,"lon":391},{"facility":395,"status":91,"city":387,"state":54,"zip":396,"country":378,"countryCode":379,"cosmosGeoPoint":397,"geoPoint":399,"contacts":54},"Climb Bio Investigative Site #805","03151",{"type":98,"coordinates":398},[391,392],{"lat":392,"lon":391},{"facility":401,"status":91,"city":402,"state":54,"zip":403,"country":378,"countryCode":379,"cosmosGeoPoint":404,"geoPoint":408,"contacts":54},"Climb Bio Investigative Site #804","Rivne","33027",{"type":98,"coordinates":405},[406,407],26.23695,50.62036,{"lat":407,"lon":406},{"facility":410,"status":91,"city":411,"state":54,"zip":412,"country":378,"countryCode":379,"cosmosGeoPoint":413,"geoPoint":417,"contacts":54},"Climb Bio Investigative Site #802","Ternopil","46002",{"type":98,"coordinates":414},[415,416],25.59067,49.55404,{"lat":416,"lon":415},{"type":419,"investigatorFullName":54,"investigatorTitle":54,"investigatorAffiliation":54,"oldNameTitle":54,"oldOrganization":54},"SPONSOR","100600388","phase-2-a-phase-2-study-of-budoprutug-in-subjects-with-primary-membranous-nephropathy-100600388",false,"NCT07096843","A Phase 2 Study of Budoprutug in Subjects With Primary Membranous Nephropathy","A Phase 2, Open-Label Study to Evaluate the Safety and Efficacy of Budoprutug (TNT119) in Subjects With Primary Membranous Nephropathy (PMN)","PrisMN","Inclusion Criteria:\n\n* Confirmed diagnosis of PMN with positive anti-PLA2R antibodies\n* CD19+ B cell count ≥40 cells\u002FμL\n* UPCR ≥2.0 g\u002Fg\n* eGFR ≥35 mL\u002Fmin\u002F1.73 m²\n* Stable RAAS inhibitor therapy\n* Blood pressure \\\u003C150\u002F90 mmHg at baseline\n* Adequate hematologic, hepatic, and renal function\n* Willing to use effective contraception (both sexes)\n* Other inclusion criteria may apply\n\nExclusion Criteria:\n\n* Secondary Membranous Nephropathy\n* Rapidly progressive glomerulonephritis or other glomerulopathies\n* Prior B cell-depleting therapy within 24 weeks\n* Recent use of immunosuppressants\n* Active or high-risk infections\n* History of malignancy\n* Pregnancy or breastfeeding\n* Recent major surgery or hospitalization\n* Other exclusion criteria may apply","ALL","18 Years","75 Years",{"count":432,"type":433},45,"ESTIMATED","INTERVENTIONAL",[436],"PHASE2","To evaluate the safety and tolerability of three dose regimens of budoprutug in subjects with PMN",[439],"Primary Membranous Nephropathy",[441,442,426],"PMN","Anti-CD19","2026-10-06",{"date":445,"type":446},"2026-10-08","ACTUAL",{"date":448,"type":446},"2025-08-25",{"date":450,"type":433},"2027-10",{"name":5,"class":6},38]